An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022535
Company: LEGACY PHARMA

Summary Review

Products on NDA 022535

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ESBRIET	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022535

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/15/2014	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022535s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022535Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/022535Orig1s000toc.html https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/022535Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/24/2023	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208780s007,022535s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208780Orig1s007;022535Orig1s016ltr.pdf
02/11/2022	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022535Orig1s015; 208780Orig1s005ltr.pdf
07/31/2019	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022535s012,208780s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022535Orig1s012, 208780Orig1s002ltr.pdf
01/11/2017	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022535s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022535Orig1s005ltr.pdf
01/11/2017	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
06/08/2016	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.
09/24/2015	SUPPL-1	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022535s001lbl.pdf

Labels for NDA 022535

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/24/2023	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208780s007,022535s016lbl.pdf
02/11/2022	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022535s015,208780s005lbl.pdf
07/31/2019	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022535s012,208780s002lbl.pdf
01/11/2017	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022535s005lbl.pdf
09/24/2015	SUPPL-1	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022535s001lbl.pdf
10/15/2014	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022535s000lbl.pdf

Therapeutic Equivalents for NDA 022535

ESBRIET

CAPSULE;ORAL; 267MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ESBRIET	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	Yes	AB	022535	LEGACY PHARMA
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212731	ACCORD HLTHCARE
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212569	AMNEAL
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212597	AUROBINDO PHARMA
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212724	LAURUS
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212748	MACLEODS PHARMS LTD
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212600	SANDOZ
PIRFENIDONE	PIRFENIDONE	267MG	CAPSULE;ORAL	Prescription	No	AB	212077	SCIEGEN PHARMS

Top